Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Quint JK, Donaldson GC, Goldring JJ, Baghai-Ravary R, Hurst JR, Wedzicha JA.

Chest. 2010 Apr;137(4):812-22. doi: 10.1378/chest.09-1541. Epub 2009 Oct 16.

2.

Human rhinovirus infection during naturally occurring COPD exacerbations.

George SN, Garcha DS, Mackay AJ, Patel AR, Singh R, Sapsford RJ, Donaldson GC, Wedzicha JA.

Eur Respir J. 2014 Jul;44(1):87-96. doi: 10.1183/09031936.00223113. Epub 2014 Mar 13.

3.

Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.

Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA.

Eur Respir J. 2000 Oct;16(4):677-83.

4.

Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.

Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA.

Chest. 2006 Feb;129(2):317-24.

PMID:
16478847
5.

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.

Quint JK, Donaldson GC, Wassef N, Hurst JR, Thomas M, Wedzicha JA.

BMC Pulm Med. 2012 Jun 22;12:28. doi: 10.1186/1471-2466-12-28.

6.

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.

Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L, Papi A, Stanciu LA, Kon OM, Johnson M, Johnston SL.

Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.

7.

Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.

Denlinger LC, Sorkness RL, Lee WM, Evans MD, Wolff MJ, Mathur SK, Crisafi GM, Gaworski KL, Pappas TE, Vrtis RF, Kelly EA, Gern JE, Jarjour NN.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1007-14. doi: 10.1164/rccm.201103-0585OC.

8.

Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.

Roland M, Bhowmik A, Sapsford RJ, Seemungal TA, Jeffries DJ, Warner TD, Wedzicha JA.

Thorax. 2001 Jan;56(1):30-5.

9.

[Comparison of the detection rate and load of rhinovirus in nasal versus lower airway samples from patients with chronic obstructive pulmonary disease].

Liao H, Chen R, Guan W, Yang Z, Liu W, Zhou R, Zhong N.

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Jan;37(1):21-3. Chinese.

PMID:
24694969
10.

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, Lindblad K, Patel H, Rugman P, Dodson P, Jenkins M, Saunders M, Newbold P, Green RH, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE.

Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71. doi: 10.1164/rccm.201104-0597OC.

PMID:
21680942
11.

[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].

Saldías PF, Díaz PO, Dreyse DJ, Gaggero BA, Sandoval AC, Lisboa BC.

Rev Med Chil. 2012 Jan;140(1):10-8. doi: /S0034-98872012000100002. Epub 2012 Apr 12. Spanish.

12.

Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection.

Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D.

Am J Physiol Lung Cell Mol Physiol. 2005 Jul;289(1):L85-95. Epub 2005 Mar 11.

13.

Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.

Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo MB, Kebadze T, Aniscenko J, Oleszkiewicz G, Gray K, Message SD, Ito K, Barnes PJ, Adcock IM, Papi A, Stanciu LA, Elkin SL, Kon OM, Johnson M, Johnston SL.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.

14.

Non-invasive biomarkers in exacerbations of obstructive lung disease.

Warwick G, Thomas PS, Yates DH.

Respirology. 2013 Jul;18(5):874-84. doi: 10.1111/resp.12089.

PMID:
23521049
15.

Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.

Chang CH, Tsao KC, Hu HC, Huang CC, Kao KC, Chen NH, Yang CT, Tsai YH, Hsieh MJ.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:767-74. doi: 10.2147/COPD.S76740. eCollection 2015.

16.

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA.

Thorax. 2000 Feb;55(2):114-20.

17.

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.

Footitt J, Mallia P, Durham AL, Ho WE, Trujillo-Torralbo MB, Telcian AG, Del Rosario A, Chang C, Peh HY, Kebadze T, Aniscenko J, Stanciu L, Essilfie-Quaye S, Ito K, Barnes PJ, Elkin SL, Kon OM, Wong WS, Adcock IM, Johnston SL.

Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.

18.

Factors associated with symptomatic rhinovirus infection in patients with COPD.

Gandhi A, Walsh EE, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Baran A, Falsey AR.

J Clin Virol. 2012 Dec;55(4):343-7. doi: 10.1016/j.jcv.2012.08.020. Epub 2012 Sep 19.

PMID:
22999488
19.

C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.

Gallego M, Pomares X, Capilla S, Marcos MA, Suárez D, Monsó E, Montón C.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 21;11:2633-2640. eCollection 2016.

20.

Comparison of sampling methods for the detection of human rhinovirus RNA.

Waris M, Österback R, Lahti E, Vuorinen T, Ruuskanen O, Peltola V.

J Clin Virol. 2013 Sep;58(1):200-4. doi: 10.1016/j.jcv.2013.06.002. Epub 2013 Jun 27.

PMID:
23810645

Supplemental Content

Support Center